A doctor, a patient and a former federal official weigh in on Medicare’s recent move to restrict access to the first new Alzheimer’s treatment in nearly 20 years.

DONATE

Reporting on complex health policy issues is no easy task. By supporting Tradeoffs, you help make our ambitious storytelling, relentless fact finding, and rigorous research possible.

Tradeoffs (EIN: 834075323) is a 501(c)(3) organization.

RECENT STORIES

Explore all of our episodes

Medicare’s Unprecedented Alzheimer’s Drug Decision

A doctor, a patient and a former federal official weigh in on Medicare's recent move to restrict access to a new Alzheimer's treatment.

Read More

Best Health Care Podcasts of 2021

We look back on some of the best health care podcast episodes as determined by a few of our podcast host friends.

Read More

Winter Hiatus Episodes

Explore the guest and rerun episodes we featured in the Tradeoffs podcast feed during our winter 2021-2022 hiatus.

Read More

As Featured In: